Patent · US Active

Antibodies specific to MUC18

US12364770B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

Multitude Inc. · CN

Inventors

Bing Hou · Shanghai, CN
Guangcun Cheng · Shanghai, CN
Shaofei Zhang · Raleigh, US
Na Wang · San Jose, US
Shu-Hui Liu · Redwood City, US
Xun Meng · Shanghai, CN

Key dates

Filing date	Jun 17, 2021
Grant date	Jul 22, 2025
Priority date	—
Expiry date	Feb 24, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/50
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies specific to MUC18 (a.k.a. MCAM or CD146) and antibody-drug conjugates (ADCs) comprising such. Also provided herein are uses the the anti-MUC18 antibodies or ADCs for therapeutic and diagnostic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.